Stereoselective interaction of the azole antifungal agent SCH39304 with the cytochrome P-450 monooxygenase system isolated from Cryptococcus neoformans

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1465-1467

  Lamb, David C ^a   Baldwin, Brian C ^b   Kwon Chung, K J ^c   Kelly, Steven L ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b JEALOTT S HILL RESEARCH STATION   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ERGOSTEROL; FLUCONAZOLE; GENACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; DRUG PROTEIN BINDING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 0030745233     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1465     Document Type: Article

References (15)

1. Baldwin, B. C., and T. E. Wiggins. 1984. Action of fungicidal triazoles of the diclobutrazol series on Ustilago maydis. Pestic. Sci. 15:156-166.
2. Ballard, S. A., S. W. Ellis, S. L. Kelly, and P. F. Troke. 1990. Interaction of microsomal cytochrome P450 isolated from Aspergillus fumigatus with fluconazole and itraconazole. J. Med. Vet. Mycol. 28:335-3344.
3. Carelli, A., G. Farina, F. Gozzo, L. Merlini, and S. L. Kelly. 1990. Interaction of tetraconazole and its enantiomers with cytochrome P450 from Ustilago maydis. Pestic. Sci. 35:167-170.
4. Diamond, R. D., and J. E. Bennett. 1974. Prognostic factors in cryptococcal meningitis. Ann Intern. Med. 80:176-181.
5. Grabski, C., and U. Gisi. 1990. Sensitivity and sterol profile of plant pathogenic fungi treated with cyproconazole. Tagungsber. Akad. Landwirtschaftswissenschaften DDR 291:95-100.
6. Kelly, S. L., and D. E. Kelly. 1993. Molecular studies on azole sensitivity in fungi, p. 199-213. In B. Maresca, G. S. Kobayashi, and H. Yamaguchi, (ed.), Molecular biology and applications to medical mycology. Springer-Verlag, Berlin, Germany.
7. Kelly, S. L., D. C. Lamb, A. J. Corran, B. C. Baldwin, and D. E. Kelly. 1995. Mode of action and resistance to azole antifungals is associated with the formation of 14α-methylergosta-8,24(28)-dien-3β,6α-diol. Biochem. Biophys. Res. Commun. 207:910-915.
8. Kelly, S. L., D. C. Lamb, A. J. Corran, B. C. Baldwin, and D. E. Kelly. 1995. Purification and reconstitution of activity of Saccharomyces cerevisiae P45061, a sterol 22-desaturase. FEBS Lett. 131:337-341.
9. Kwon-Chung, K. J., J. C. Edman and B. L. Wickes. 1992. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect. Immun. 60:602-605.
10. Lamb, D. C., A. J. Corran, B. C. Baldwin, J. Kwon-Chung, and S. L. Kelly. 1995. Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans. FEBS Lett. 368:326-330.
11. Lowry, O. H., N. J. Rosenbrough, A. O. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:928-929.
12. Omura, T., and R. Sato. 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239:2370-2378.
13. Yoshida, Y., and Y. Aoyama. 1986. Interaction of azole fungicides with cytochrome P450 which catalyses lanosterol 14α-demethylation, p. 123-134. In K. Iwata and H. Vanden Bossche (ed.), In vitro and in vivo evaluation as antifungal agents. Elsevier. Amsterdam, The Netherlands.
14. 14DM purified from Saccharomyces cerevisiae microsomes. Biochem. Pharmacol. 36:229-235.
15. Yoshida, Y., and Y. Aoyama. 1990. Stereoselective interaction of an azole antifungal agent with its target, lanosterol 14α-demethylase. Chirality 2:10-15.